Research programme: epidermal growth factor kinase inhibitors - ImClone SystemsAlternative Names: IM 092214
Latest Information Update: 26 Jul 2006
At a glance
- Originator ImClone Systems
- Class Small molecules
- Mechanism of Action Epidermal growth factor receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 31 Dec 2005 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 05 May 2005 Preclinical trials in Cancer in USA (unspecified route)